Jie Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jie Sun has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Wei Yuan
Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China
4 shared publications - Yinjun Zhang
Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China
4 shared publications Zhao Wang
Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310014, China
4 shared publications- Kechen Yu
Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China
3 shared publications - Tingheng Zhu
College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China
3 shared publications Chun Wei
Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China
2 shared publications
Latest Publications
- Open Access
- 30 July 2026
- Published by Elsevier in SSRN Electronic Journal
Metabolic Engineering of Saccharomyces cerevisiae for Glucaric Acid Production from Rice Straw Hydrolysate
Rice straw is among the most abundant agricultural residues, yet its conversion into bio-based chemicals is hindered by the complex sugar-inhibitor mixture in its hydrolysate. D-Glucaric acid (GA), a U.S. Department of Energy top-value platform chemical, serves as a monomer for biodegradable polymers. We developed an integrated bioprocess in Saccharomyces cerevisiae combining metabolic engineering with adaptive laboratory evolution (ALE) to convert rice straw hydrolysate into GA. Carbon catabolite repression was alleviated via MIG1 disruption; a xylose-inducible isomerase pathway enabled glucose-xylose co-utilization; and the GA pathway was amplified through multi-copy integration of MIOX4, UDH, and INO1 with knockouts of competing nodes (ZWF1, PGI1, PFK2). ALE directly in rice straw hydrolysate selected for improved xylose consumption and inhibitor tolerance. The final strain produced 4.84 g/L GA in shake-flask hydrolysate and 16.90 g/L in a 5-L fed-batch bioreactor, the highest GA titer from real lignocellulosic hydrolysate reported to date. This work demonstrates how pathway engineering, directed evolution, and bioreactor scale-up can convert agricultural residues into platform chemicals.
- 30 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMetabolic Engineering of Saccharomyces cerevisiae for Glucaric Acid Production from Rice Straw Hydrolysate
Rice straw is among the most abundant agricultural residues, yet its conversion into bio-based chemicals is hindered by the complex sugar-inhibitor mixture in its hydrolysate. D-Glucaric acid (GA), a U.S. Department of Energy top-value platform chemical, serves as a monomer for biodegradable polymers. We developed an integrated bioprocess in Saccharomyces cerevisiae combining metabolic engineering with adaptive laboratory evolution (ALE) to convert rice straw hydrolysate into GA. Carbon catabolite repression was alleviated via MIG1 disruption; a xylose-inducible isomerase pathway enabled glucose-xylose co-utilization; and the GA pathway was amplified through multi-copy integration of MIOX4, UDH, and INO1 with knockouts of competing nodes (ZWF1, PGI1, PFK2). ALE directly in rice straw hydrolysate selected for improved xylose consumption and inhibitor tolerance. The final strain produced 4.84 g/L GA in shake-flask hydrolysate and 16.90 g/L in a 5-L fed-batch bioreactor, the highest GA titer from real lignocellulosic hydrolysate reported to date. This work demonstrates how pathway engineering, directed evolution, and bioreactor scale-up can convert agricultural residues into platform chemicals.
- 8 July 2025
- Published by Springer Nature in 3 Biotech
- Vol. 15 (8) , 1-9
Construction of engineered Saccharomyces cerevisiae for producing phytosphingosine
Phytosphingosine (PHS), a sphingolipid-derived bioactive compound, exhibits multifunctional properties including antimicrobial activity, skin moisturization, and hydration, rendering it highly valuable for cosmetic and pharmaceutical applications. Through systematic metabolic engineering of Saccharomyces cerevisiae, we achieved 82.62 mg/g DCW phytosphingosine (PHS) production via integrated pathway optimization and stress mitigation. Key strategies involved: (1) Knockout of LCB4 (sphingoid long-chain base kinase), SHM2 (serine hydroxymethyltransferase), and CHA1 (l-serine deaminase) to block competitive pathways; (2) Overexpression of TSC10 (3-ketosphingosine reductase), SYR2 (sphingosine hydroxylase), and LCB1/LCB2 (serine palmitoyltransferase) to amplify the PHS synthesis flux. Initial shake flask fermentation (96 h) yielded 15.31 mg/g DCW of PHS, with ORM2 knockout providing a 73.6% productivity increase (26.54 mg/g DCW) despite inducing growth defects from sphingosine accumulation. We hypothesized that disrupted ORM2-mediated control of serine palmitoyltransferase activity might compromise ER homeostasis through sphingolipid imbalance, which was alleviated through HAC1 overexpression to enhance unfolded protein response (UPR) capacity. Fed-batch fermentation under optimized conditions (40 mM serine, 0.5 mM palmitic acid, pH 5) demonstrated scalable production, delivering a 5.4-fold improvement over baseline. This work establishes UPR engineering as a critical strategy for resolving lipid toxicity constraints in yeast sphingolipid biosynthesis, while highlighting S. cerevisiae's potential as an industrial PHS production platform through coordinated pathway and stress response manipulation.
- 8 July 2025
- Published by Springer Nature in 3 Biotech
- Vol. 15 (8) , 1-9
Construction of engineered Saccharomyces cerevisiae for producing phytosphingosine
Phytosphingosine (PHS), a sphingolipid-derived bioactive compound, exhibits multifunctional properties including antimicrobial activity, skin moisturization, and hydration, rendering it highly valuable for cosmetic and pharmaceutical applications. Through systematic metabolic engineering of Saccharomyces cerevisiae, we achieved 82.62 mg/g DCW phytosphingosine (PHS) production via integrated pathway optimization and stress mitigation. Key strategies involved: (1) Knockout of LCB4 (sphingoid long-chain base kinase), SHM2 (serine hydroxymethyltransferase), and CHA1 (l-serine deaminase) to block competitive pathways; (2) Overexpression of TSC10 (3-ketosphingosine reductase), SYR2 (sphingosine hydroxylase), and LCB1/LCB2 (serine palmitoyltransferase) to amplify the PHS synthesis flux. Initial shake flask fermentation (96 h) yielded 15.31 mg/g DCW of PHS, with ORM2 knockout providing a 73.6% productivity increase (26.54 mg/g DCW) despite inducing growth defects from sphingosine accumulation. We hypothesized that disrupted ORM2-mediated control of serine palmitoyltransferase activity might compromise ER homeostasis through sphingolipid imbalance, which was alleviated through HAC1 overexpression to enhance unfolded protein response (UPR) capacity. Fed-batch fermentation under optimized conditions (40 mM serine, 0.5 mM palmitic acid, pH 5) demonstrated scalable production, delivering a 5.4-fold improvement over baseline. This work establishes UPR engineering as a critical strategy for resolving lipid toxicity constraints in yeast sphingolipid biosynthesis, while highlighting S. cerevisiae's potential as an industrial PHS production platform through coordinated pathway and stress response manipulation.
- Open Access
Multi-Enzymatic Cascade for Efficient Deracemization of dl-Pantolactone into d-Pantolactone
D-pantolactone is an intermediate in the synthesis of d-pantothenic acid, which is known as vitamin B5. The commercial synthesis of d-pantolactone is carried out through the selective resolution of dl-pantolactone catalyzed by lactone hydrolase. In contrast to a kinetic resolution approach, the deracemization of dl-pantolactone is a simpler, greener, and more sustainable way to obtain d-pantolactone with high optical purity. Herein, an efficient three-enzyme cascade was developed for the deracemization of dl-pantolactone, using l-pantolactone dehydrogenase from Amycolatopsis methanolica (AmeLPLDH), conjugated polyketone reductase from Zygosaccharomyces parabailii (ZpaCPR), and glucose dehydrogenase from Bacillus subtilis (BsGDH). The AmeLPLDH was used to catalyze the dehydrogenated l-pantolactone into ketopantolactone; the ZpaCPR was used to further catalyze the ketopantolactone into d-pantolactone; and glucose dehydrogenase together with glucose fulfilled the function of coenzyme regeneration. All three enzymes were co-expressed in E. coli strain BL21(DE3), which served as the whole-cell biocatalyst. Under optimized conditions, 36 h deracemization of 1.25 M dl-pantolactone d-pantolactone led to an e.e.p value of 98.6%, corresponding to productivity of 107.7 g/(l·d).
Open AccessMulti-Enzymatic Cascade for Efficient Deracemization of dl-Pantolactone into d-Pantolactone
D-pantolactone is an intermediate in the synthesis of d-pantothenic acid, which is known as vitamin B5. The commercial synthesis of d-pantolactone is carried out through the selective resolution of dl-pantolactone catalyzed by lactone hydrolase. In contrast to a kinetic resolution approach, the deracemization of dl-pantolactone is a simpler, greener, and more sustainable way to obtain d-pantolactone with high optical purity. Herein, an efficient three-enzyme cascade was developed for the deracemization of dl-pantolactone, using l-pantolactone dehydrogenase from Amycolatopsis methanolica (AmeLPLDH), conjugated polyketone reductase from Zygosaccharomyces parabailii (ZpaCPR), and glucose dehydrogenase from Bacillus subtilis (BsGDH). The AmeLPLDH was used to catalyze the dehydrogenated l-pantolactone into ketopantolactone; the ZpaCPR was used to further catalyze the ketopantolactone into d-pantolactone; and glucose dehydrogenase together with glucose fulfilled the function of coenzyme regeneration. All three enzymes were co-expressed in E. coli strain BL21(DE3), which served as the whole-cell biocatalyst. Under optimized conditions, 36 h deracemization of 1.25 M dl-pantolactone d-pantolactone led to an e.e.p value of 98.6%, corresponding to productivity of 107.7 g/(l·d).
- Open Access
- 12 December 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (12) , 2454
The Production of Pyruvate in Biological Technology: A Critical Review
Pyruvic acid has numerous applications in the food, chemical, and pharmaceutical industries. The high costs of chemical synthesis have prevented the extensive use of pyruvate for many applications. Metabolic engineering and traditional strategies for mutation and selection have been applied to microorganisms to enhance their ability to produce pyruvate. In the past decades, different microbial strains were generated to enhance their pyruvate production capability. In addition to the development of genetic engineering and metabolic engineering in recent years, the metabolic transformation of wild-type yeast, E. coli, and so on to produce high-yielding pyruvate strains has become a hot spot. The strategy and the understanding of the central metabolism directly related to pyruvate production could provide valuable information for improvements in fermentation products. One of the goals of this review was to collect information regarding metabolically engineered strains and the microbial fermentation processes used to produce pyruvate in high yield and productivity.
- 12 December 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (12) , 2454
Open AccessThe Production of Pyruvate in Biological Technology: A Critical Review
Pyruvic acid has numerous applications in the food, chemical, and pharmaceutical industries. The high costs of chemical synthesis have prevented the extensive use of pyruvate for many applications. Metabolic engineering and traditional strategies for mutation and selection have been applied to microorganisms to enhance their ability to produce pyruvate. In the past decades, different microbial strains were generated to enhance their pyruvate production capability. In addition to the development of genetic engineering and metabolic engineering in recent years, the metabolic transformation of wild-type yeast, E. coli, and so on to produce high-yielding pyruvate strains has become a hot spot. The strategy and the understanding of the central metabolism directly related to pyruvate production could provide valuable information for improvements in fermentation products. One of the goals of this review was to collect information regarding metabolically engineered strains and the microbial fermentation processes used to produce pyruvate in high yield and productivity.
- Open Access
- 30 August 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (9) , 1746
Accumulation and Enrichment of Trace Elements by Yeast Cells and Their Applications: A Critical Review
Maintaining the homeostasis balance of trace elements is crucial for the health of organisms. Human health is threatened by diseases caused by a lack of trace elements. Saccharomyces cerevisiae has a wide and close relationship with human daily life and industrial applications. It can not only be used as fermentation products and single-cell proteins, but also as a trace elements supplement that is widely used in food, feed, and medicine. Trace-element-enriched yeast, viz., chromium-, iron-, zinc-, and selenium-enriched yeast, as an impactful microelements supplement, is more efficient, more environmentally friendly, and safer than its inorganic and organic counterparts. Over the last few decades, genetic engineering has been developing large-scaled genetic re-design and reconstruction in yeast. It is hoped that engineered yeast will include a higher concentration of trace elements. In this review, we compare the common supplement forms of several key trace elements. The mechanisms of detoxification and transport of trace elements in yeast are also reviewed thoroughly. Moreover, genes involved in the transport and detoxification of trace elements are summarized. A feasible way of metabolic engineering transformation of S. cerevisiae to produce trace-element-enriched yeast is examined. In addition, the economy, safety, and environmental protection of the engineered yeast are explored, and the future research direction of yeast enriched in trace elements is discussed.
- 30 August 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (9) , 1746
Open AccessAccumulation and Enrichment of Trace Elements by Yeast Cells and Their Applications: A Critical Review
Maintaining the homeostasis balance of trace elements is crucial for the health of organisms. Human health is threatened by diseases caused by a lack of trace elements. Saccharomyces cerevisiae has a wide and close relationship with human daily life and industrial applications. It can not only be used as fermentation products and single-cell proteins, but also as a trace elements supplement that is widely used in food, feed, and medicine. Trace-element-enriched yeast, viz., chromium-, iron-, zinc-, and selenium-enriched yeast, as an impactful microelements supplement, is more efficient, more environmentally friendly, and safer than its inorganic and organic counterparts. Over the last few decades, genetic engineering has been developing large-scaled genetic re-design and reconstruction in yeast. It is hoped that engineered yeast will include a higher concentration of trace elements. In this review, we compare the common supplement forms of several key trace elements. The mechanisms of detoxification and transport of trace elements in yeast are also reviewed thoroughly. Moreover, genes involved in the transport and detoxification of trace elements are summarized. A feasible way of metabolic engineering transformation of S. cerevisiae to produce trace-element-enriched yeast is examined. In addition, the economy, safety, and environmental protection of the engineered yeast are explored, and the future research direction of yeast enriched in trace elements is discussed.
- Open Access
Engineering the Activity of Old Yellow Enzyme NemR-PS for Efficient Reduction of (E/Z)-Citral to (S)-Citronellol
The cascade catalysis of old yellow enzyme, alcohol dehydrogenase and glucose dehydrogenase has become a promising approach for one pot, two-step reduction of (E/Z)-citral to (S)-citronellol, serving as a chiral alcohol with rose fragrance. During the multi-enzymatic cascade catalysis, old yellow enzyme is responsible for the reduction of the conjugated C=C and the introduction of the chiral center, requiring high activity and (S)-enantioselectiviy. Herein, to improve the activity of the old yellow enzyme from Providencia stuartii (NemR-PS) with strict (S)-enantioselectivity, the semi-rational design on its substrate binding pocket was performed through a combination of homology modeling, molecular docking analysis, alanine scanning and iterative saturation mutagenesis. The NemR-PS variant D275G/F351A with improved activity was obtained and then purified for characterization, obeying the substrate inhibition kinetics. Compared with the wild type, the parameters Ki and Kcat/Km were increased from 39.79 mM and 2.09 s−1mM−1 to 128.50 mM and 5.01 s−1mM−1, respectively. Moreover, the variant D275G/F351A maintained strict (S)-enantioselectivity, avoiding the trade-off effect between activity and enantioselectivity. Either the enzyme NemR-PS or the variant D275G/F351A was co-expressed with alcohol dehydrogenase from Yokenella sp. WZY002 (YsADH) and glucose dehydrogenase from Bacillus megaterium (BmGDHM6). In contrast to the whole-cell biocatalyst co-expressing NemR-PS, that co-expressing the variant D275G/F351A shortened the reaction time from 36 h to 12 h in the reduction of 400 mM (E/Z)-citral. In the manner of substrate constant feeding, the accumulated product concentration reached up to 500 mM and completely eliminate the residual intermediate and by-product, suggesting the effectiveness of protein engineering and substrate engineering to improve catalytic efficiency.
Open AccessEngineering the Activity of Old Yellow Enzyme NemR-PS for Efficient Reduction of (E/Z)-Citral to (S)-Citronellol
The cascade catalysis of old yellow enzyme, alcohol dehydrogenase and glucose dehydrogenase has become a promising approach for one pot, two-step reduction of (E/Z)-citral to (S)-citronellol, serving as a chiral alcohol with rose fragrance. During the multi-enzymatic cascade catalysis, old yellow enzyme is responsible for the reduction of the conjugated C=C and the introduction of the chiral center, requiring high activity and (S)-enantioselectiviy. Herein, to improve the activity of the old yellow enzyme from Providencia stuartii (NemR-PS) with strict (S)-enantioselectivity, the semi-rational design on its substrate binding pocket was performed through a combination of homology modeling, molecular docking analysis, alanine scanning and iterative saturation mutagenesis. The NemR-PS variant D275G/F351A with improved activity was obtained and then purified for characterization, obeying the substrate inhibition kinetics. Compared with the wild type, the parameters Ki and Kcat/Km were increased from 39.79 mM and 2.09 s−1mM−1 to 128.50 mM and 5.01 s−1mM−1, respectively. Moreover, the variant D275G/F351A maintained strict (S)-enantioselectivity, avoiding the trade-off effect between activity and enantioselectivity. Either the enzyme NemR-PS or the variant D275G/F351A was co-expressed with alcohol dehydrogenase from Yokenella sp. WZY002 (YsADH) and glucose dehydrogenase from Bacillus megaterium (BmGDHM6). In contrast to the whole-cell biocatalyst co-expressing NemR-PS, that co-expressing the variant D275G/F351A shortened the reaction time from 36 h to 12 h in the reduction of 400 mM (E/Z)-citral. In the manner of substrate constant feeding, the accumulated product concentration reached up to 500 mM and completely eliminate the residual intermediate and by-product, suggesting the effectiveness of protein engineering and substrate engineering to improve catalytic efficiency.
- 6 June 2022
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 106 (11) , 4041-4052
The same genetic regulation strategy produces inconsistent effects in different Saccharomyces cerevisiae strains for 2-phenylethanol production
A CRISPR/Cas9 system with gene editing efficiency of 100% in the industrial diploid Saccharomyces cerevisiae CWY-132 strain for 2-phenylethanol (2-PE) prod
- 6 June 2022
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 106 (11) , 4041-4052
The same genetic regulation strategy produces inconsistent effects in different Saccharomyces cerevisiae strains for 2-phenylethanol production
A CRISPR/Cas9 system with gene editing efficiency of 100% in the industrial diploid Saccharomyces cerevisiae CWY-132 strain for 2-phenylethanol (2-PE) prod
- 20 March 2022
- Published by Springer Nature in 3 Biotech
- Vol. 12 (4) , 1-9
Engineering of Yarrowia lipolytica for producing pyruvate from glycerol
The present study aims to increase pyruvate production by engineering Yarrowia lipolytica through modifying the glycerol metabolic pathway. Results: Wild-type Yarrowia lipolytica (Po1d) was engineered to produce six different strains, namely ZS099 (by over-expressing PYK1), ZS100 (by deleting DGA2), ZS101 (by over-expressing DAK1, DAK2, and GCY1), ZS102 (by over-expressing GUT1 and GUT2), ZS103 (by over-expressing GUT1) and ZSGP (by over-expressing POS5 and deleting GPD2). Production of pyruvate from engineered and control strains was determined using high-performance liquid chromatography (HPLC). Subsequently, the fermentation conditions for producing pyruvate were optimized, including the amount of initial inoculation, the addition of calcium carbonate (CaCO3), thiamine and glycerol. Finally, for scaled-up purposes, a 20-L fermentor was used. It was observed that pyruvate production increased by 136% (8.55 g/L) in ZSGP strain compared to control (3.62 g/L). Furthermore, pyruvate production by ZSGP reached up to 110.4 g/L in 96 h in the scaled-up process. We conclude that ZSGP strain of Y. lipolytica can be effectively used for pyruvate production at the industrial level.
- 20 March 2022
- Published by Springer Nature in 3 Biotech
- Vol. 12 (4) , 1-9
Engineering of Yarrowia lipolytica for producing pyruvate from glycerol
The present study aims to increase pyruvate production by engineering Yarrowia lipolytica through modifying the glycerol metabolic pathway. Results: Wild-type Yarrowia lipolytica (Po1d) was engineered to produce six different strains, namely ZS099 (by over-expressing PYK1), ZS100 (by deleting DGA2), ZS101 (by over-expressing DAK1, DAK2, and GCY1), ZS102 (by over-expressing GUT1 and GUT2), ZS103 (by over-expressing GUT1) and ZSGP (by over-expressing POS5 and deleting GPD2). Production of pyruvate from engineered and control strains was determined using high-performance liquid chromatography (HPLC). Subsequently, the fermentation conditions for producing pyruvate were optimized, including the amount of initial inoculation, the addition of calcium carbonate (CaCO3), thiamine and glycerol. Finally, for scaled-up purposes, a 20-L fermentor was used. It was observed that pyruvate production increased by 136% (8.55 g/L) in ZSGP strain compared to control (3.62 g/L). Furthermore, pyruvate production by ZSGP reached up to 110.4 g/L in 96 h in the scaled-up process. We conclude that ZSGP strain of Y. lipolytica can be effectively used for pyruvate production at the industrial level.
- Open Access
- 1 April 2021
- Published by Springer Nature in Research Square
Construction of CRISPR/CAS9 system for industrial Saccharomyces cerevisiae strain and genetic manipulation effect on 2-phenylethanol pathway
Background The market demand for natural 2-phenylethanol (2-PE) continues to increase. Saccharomyces cerevisiae can synthesize 2-PE through the Ehrlich pathway. There are few studies on the improvement of the diploid industrial strains of S. cerevisiae by gene editing technology. There is no report on the comparison of genetic manipulation effect among S.cerevisiae strains with different 2-PE yield background, and the study on knockout of 2-PE downstream product synthesis gene and its effect on the yield of 2-PE have not been found. Results The CRISPR/CAS9 system with high efficiency for diploid S.cerevisiae CWY132 strain for industrial production of 2-PE was constructed. When the length of the homology arm of donor DNA is increased from 60bp to 500bp, the efficiency of gene editing increased from 0–100%. Using CRISPR/CAS9 technology, the branched acetaldehyde dehydrogenase genes ALD2 and ALD3 and the terminal acetyltransferase gene ATF1 in the Ehrlich pathway of S.cerevisiae strains with different 2-PE yields were knocked out. The results showed that in the high-yielding CWY-132 strain, the 2-PE yield decreased from 3.50 g/L to 1.65 g/L when double ALD2 and ALD3 were knocked out, a decrease of 52.8%. When ATF1 was knocked out, the yield of 2-PE decreased to 0.83 g/L, a decrease of 76.2%; In the low-yielding strain PK-2C, the yield of 2-PE increased from 0.21 g/L to 1.20 g/L when ALD2 was knocked out, an increase of 471%. When ATF1 was knocked out, the yield of 2-PE increased to 0.45g/L, an increase of 114%. The results show that the same genetic manipulation strategy for strains with different 2-PE yeilds backgrounds produces significantly different or even opposite effects. In addition, we found that the insufficient supply of NADH in cells can significantly affect the production of 2-PE, and the tolerance of cells to 2-PE is also a key factor that limits the further increase of 2-PE production in high-yielding strain. Conclusions This study shows that the length of the Donor DNA homology arm is a key factor affecting the efficiency of CRISPR/CAS9 gene editing in industrial diploid S. cerevisiae strains. Our result also shows that it is not feasible to increase the 2-PE production in high-yielding strains by blocking the branch pathway in the Ehrlich pathway. Breakthrough in the 2-PE yield of the high-yielding strains requires improved strains’ tolerance to 2-PE and increase the cellular NADH level.
- 1 April 2021
- Published by Springer Nature in Research Square
Open AccessConstruction of CRISPR/CAS9 system for industrial Saccharomyces cerevisiae strain and genetic manipulation effect on 2-phenylethanol pathway
Background The market demand for natural 2-phenylethanol (2-PE) continues to increase. Saccharomyces cerevisiae can synthesize 2-PE through the Ehrlich pathway. There are few studies on the improvement of the diploid industrial strains of S. cerevisiae by gene editing technology. There is no report on the comparison of genetic manipulation effect among S.cerevisiae strains with different 2-PE yield background, and the study on knockout of 2-PE downstream product synthesis gene and its effect on the yield of 2-PE have not been found. Results The CRISPR/CAS9 system with high efficiency for diploid S.cerevisiae CWY132 strain for industrial production of 2-PE was constructed. When the length of the homology arm of donor DNA is increased from 60bp to 500bp, the efficiency of gene editing increased from 0–100%. Using CRISPR/CAS9 technology, the branched acetaldehyde dehydrogenase genes ALD2 and ALD3 and the terminal acetyltransferase gene ATF1 in the Ehrlich pathway of S.cerevisiae strains with different 2-PE yields were knocked out. The results showed that in the high-yielding CWY-132 strain, the 2-PE yield decreased from 3.50 g/L to 1.65 g/L when double ALD2 and ALD3 were knocked out, a decrease of 52.8%. When ATF1 was knocked out, the yield of 2-PE decreased to 0.83 g/L, a decrease of 76.2%; In the low-yielding strain PK-2C, the yield of 2-PE increased from 0.21 g/L to 1.20 g/L when ALD2 was knocked out, an increase of 471%. When ATF1 was knocked out, the yield of 2-PE increased to 0.45g/L, an increase of 114%. The results show that the same genetic manipulation strategy for strains with different 2-PE yeilds backgrounds produces significantly different or even opposite effects. In addition, we found that the insufficient supply of NADH in cells can significantly affect the production of 2-PE, and the tolerance of cells to 2-PE is also a key factor that limits the further increase of 2-PE production in high-yielding strain. Conclusions This study shows that the length of the Donor DNA homology arm is a key factor affecting the efficiency of CRISPR/CAS9 gene editing in industrial diploid S. cerevisiae strains. Our result also shows that it is not feasible to increase the 2-PE production in high-yielding strains by blocking the branch pathway in the Ehrlich pathway. Breakthrough in the 2-PE yield of the high-yielding strains requires improved strains’ tolerance to 2-PE and increase the cellular NADH level.
- 1 March 2020
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 134, 109485
Overexpression of the transcription factor HAC1 improves nerolidol production in engineered yeast
- 1 March 2020
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 134, 109485
Overexpression of the transcription factor HAC1 improves nerolidol production in engineered yeast